Atlas Trials

Study of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative Volunteers

Clinical trial NCT03110549 · TERMINATED

Trial details

NCT number
NCT03110549
Sponsor
TaiMed Biologics Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Human Immunodeficiency Virus
Start date
2016-11-21
Primary completion
2019-07-22
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.